Literature DB >> 34076767

Patterns of care after cholecystostomy tube placement.

Alex Lois1, Erin Fennern2, Sara Cook2, David Flum2,3,4, Giana Davidson2,3.   

Abstract

BACKGROUND: The use of cholecystostomy (c-tube) in acute cholecystitis (AC) has increased yet there is limited evidence to guide surgical decision-making after placement. As a result, there is variability in the use and timing of cholecystectomy after c-tube. We aimed to describe patient characteristics, outcomes, and biliary-related utilization in those who did and did not have cholecystectomy after c-tube.
METHODS: This is a retrospective cohort study (2007-2017) using the MarketScan® claims database of patients (18-63 years) with at least 3 months of follow-up (or death). ICD-9/10 and CPT codes were used to identify AC, c-tube placement, cholecystectomy and determine Elixhauser comorbidity index.
RESULTS: A total of 2386 patients (47.5% female, mean age 52.5 [SD 9.9] years) with AC underwent c-tube with an 11.2% 90-day mortality. Among survivors, by three months 57% underwent cholecystectomy (mean 34.8 days [95% CI: 33.3-36.3]). Cholecystectomy after c-tube was more common in those with fewer comorbid conditions (mean 2.41 [95% CI: 2.26-2.56] vs 4.56 [95%CI: 4.36-4.76]). Biliary episodes prior to cholecystectomy occurred in 12.5% and were associated with eventual cholecystectomy (HR 1.49 [1.32-1.68]). Biliary-specific hospital and ICU days were similar between groups. Biliary-specific ED visits were more common among patients with cholecystectomy (mean 1.39 [95% CI: 1.29-1.48] vs 0.94 [95% CI: 0.85-1.03]).
CONCLUSION: More than half of patients treated with c-tube underwent cholecystectomy by three months-most within five weeks of AC diagnosis. The high frequency of use and short time to cholecystectomy after c-tube raises questions about potential overuse of c-tube in the initial period. Future work should aim to understand how patient experience and indication for c-tube influence the likelihood and timing of subsequent cholecystectomy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute cholecystitis; Cholecystectomy; Cholecystostomy; Outcomes; Utilization

Mesh:

Year:  2021        PMID: 34076767      PMCID: PMC8636522          DOI: 10.1007/s00464-021-08562-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  21 in total

1.  Comparison of laparoscopic cholecystectomy and delayed laparoscopic cholecystectomy in aged acute calculous cholecystitis: a cohort study.

Authors:  Dengtian Lin; Shuodong Wu; Ying Fan; Changwei Ke
Journal:  Surg Endosc       Date:  2019-08-28       Impact factor: 4.584

2.  Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly?

Authors:  M Sugiyama; M Tokuhara; Y Atomi
Journal:  World J Surg       Date:  1998-05       Impact factor: 3.352

Review 3.  Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

Authors:  Kohji Okamoto; Kenji Suzuki; Tadahiro Takada; Steven M Strasberg; Horacio J Asbun; Itaru Endo; Yukio Iwashita; Taizo Hibi; Henry A Pitt; Akiko Umezawa; Koji Asai; Ho-Seong Han; Tsann-Long Hwang; Yasuhisa Mori; Yoo-Seok Yoon; Wayne Shih-Wei Huang; Giulio Belli; Christos Dervenis; Masamichi Yokoe; Seiki Kiriyama; Takao Itoi; Palepu Jagannath; O James Garden; Fumihiko Miura; Masafumi Nakamura; Akihiko Horiguchi; Go Wakabayashi; Daniel Cherqui; Eduardo de Santibañes; Satoru Shikata; Yoshinori Noguchi; Tomohiko Ukai; Ryota Higuchi; Keita Wada; Goro Honda; Avinash Nivritti Supe; Masahiro Yoshida; Toshihiko Mayumi; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Miin-Fu Chen; Kazunori Shibao; Keng-Hao Liu; Cheng-Hsi Su; Angus C W Chan; Dong-Sup Yoon; In-Seok Choi; Eduard Jonas; Xiao-Ping Chen; Sheung Tat Fan; Chen-Guo Ker; Mariano Eduardo Giménez; Seigo Kitano; Masafumi Inomata; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-20       Impact factor: 7.027

4.  Outcome of conservative percutaneous cholecystostomy in high-risk patients with acute cholecystitis and risk factors leading to surgery.

Authors:  Won Seok Jang; Jun Uk Lim; Kwang Ro Joo; Jae Myung Cha; Hyun Phil Shin; Sun Hyung Joo
Journal:  Surg Endosc       Date:  2014-12-09       Impact factor: 4.584

5.  What happens to biliary colic patients in New York State? 10-year follow-up from emergency department visits.

Authors:  Maria S Altieri; Jie Yang; Chencan Zhu; Samer Sbayi; Konstantinos Spaniolas; Mark Talamini; Aurora Pryor
Journal:  Surg Endosc       Date:  2017-10-23       Impact factor: 4.584

6.  Radiologically guided percutaneous cholecystostomy for acute cholecystitis: long-term outcome in 50 patients.

Authors:  R F McLoughlin; E J Patterson; J R Mathieson; P L Cooperberg; J K MacFarlane
Journal:  Can Assoc Radiol J       Date:  1994-12       Impact factor: 2.248

7.  TG13 flowchart for the management of acute cholangitis and cholecystitis.

Authors:  Fumihiko Miura; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; Dirk J Gouma; O James Garden; Markus W Büchler; Masahiro Yoshida; Toshihiko Mayumi; Kohji Okamoto; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; John A Windsor; Toshio Tsuyuguchi; Toshifumi Gabata; Takao Itoi; Jiro Hata; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027

8.  Cholecystectomy Vs. Cholecystostomy for the Management of Acute Cholecystitis in Elderly Patients.

Authors:  Francisco Schlottmann; Charles Gaber; Paula D Strassle; Marco G Patti; Anthony G Charles
Journal:  J Gastrointest Surg       Date:  2018-09-17       Impact factor: 3.452

9.  Timing of Cholecystectomy after Percutaneous Cholecystostomy for Acute Cholecystitis.

Authors:  Woo Hyun Jung; Dong Eun Park
Journal:  Korean J Gastroenterol       Date:  2015-10

Review 10.  2016 WSES guidelines on acute calculous cholecystitis.

Authors:  L Ansaloni; M Pisano; F Coccolini; A B Peitzmann; A Fingerhut; F Catena; F Agresta; A Allegri; I Bailey; Z J Balogh; C Bendinelli; W Biffl; L Bonavina; G Borzellino; F Brunetti; C C Burlew; G Camapanelli; F C Campanile; M Ceresoli; O Chiara; I Civil; R Coimbra; M De Moya; S Di Saverio; G P Fraga; S Gupta; J Kashuk; M D Kelly; V Koka; H Jeekel; R Latifi; A Leppaniemi; R V Maier; I Marzi; F Moore; D Piazzalunga; B Sakakushev; M Sartelli; T Scalea; P F Stahel; K Taviloglu; G Tugnoli; S Uraneus; G C Velmahos; I Wani; D G Weber; P Viale; M Sugrue; R Ivatury; Y Kluger; K S Gurusamy; E E Moore
Journal:  World J Emerg Surg       Date:  2016-06-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.